Company intelligence
SynOx Therapeutics
Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovial Giant Cell Tumours (TGCT)
Biotechnology Research
Dublin City, IE
34 employees
Founded 2020
1 public signals
About SynOx Therapeutics
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
Verified activity
Signals from SynOx Therapeutics
1 published signal